Voyager Therapeutics, Inc. ($VYGR)
Carter Todd Alfred โ Chief Scientific Officer
Shares
4,174
Price
$3.76
Total Value
$15,694.24
Nearby Earnings
Mar 9, 2026 ๐
EPS:-0.46 (est: -0.51)-9.9%
Revenue:$15.34M (est: $10.00M)+53.4%
Mar 10, 2026
EPS:Est: -0.54
Revenue:Est: $10.49M
Transaction Details
| Insider | Carter Todd Alfred |
|---|---|
| Title | Chief Scientific Officer |
| Transaction Date | Feb 24, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Feb 26, 2026 |
| Shares Sold | 4,174 |
| Price per Share | $3.76 |
| Total Value | $15,694.24 |
| Shares Owned After | 145,718 |
| Derivative | No |
| Accession Number | 0001104659-26-020176 |
| Document | View SEC Filing |